10 mg/kg CM-101
CM-101-SSC-203
Phase 2 small_molecule on_hold
Quick answer
10 mg/kg CM-101 for Systemic Sclerosis is a Phase 2 program (small_molecule) at Chemomab Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Chemomab Therapeutics
- Indication
- Systemic Sclerosis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- on_hold